RQM+ delivers integrated and tailored regulatory, clinical, and market access support for pharmaceutical sponsors, biotech companies, and diagnostic developers advancing companion diagnostics (CDx) and precision medicine.

Whether your goal is full commercial launch or obtaining the right regulatory clearance to support therapeutic clinical trials — such as IVDR compliance for performance studies in the EU — our MedTech experts provide fully integrated solutions to streamline approvals and align with drug development timelines.

  • MedTech-Only CRO

    100% focused on diagnostics and medical devices, with deep expertise in the co-development of companion diagnostics alongside therapeutic products.

  • Therapeutic Alignment

    Deep experience with CDER/CDRH, EMA, and IVDR co-development strategy.

  • Integrated RA/QA/CA/CRO Services

    Regulatory, clinical, and reimbursement support aligned with your drug partner’s timelines.

  • Global Compliance Experts

    U.S. FDA, EU IVDR, UKCA, and country-specific CDx frameworks (e.g., Japan PMDA).

  • Flexible Engagement Models

    Support for both commercial CDx approval and investigational-use-only strategies in the U.S., EU, and global markets.

Standards We Navigate

  • FDA 21 CFR Parts 809, 812, 814 (PMA), and 820

  • IVDR (EU 2017/746), Article 2(7), 56-77, and Annex XIII and XIV

  • EMA GVP and Companion Diagnostic Guidelines

  • ISO 13485 and ISO 20916

  • ICH Q2(R2)/Q14 (analytical validation for biomarker assays)

  • PMDA Companion Diagnostic Guidelines

  • EUnetHTA HTA Core Model® for CDx value dossiers

Expand each to see key services.

  • Biomarker strategy and validation planning
  • Regulatory pathway mapping (FDA PMA vs. 510(k), IVDR Annex I/IX)
  • Initial reimbursement feasibility and early coding strategy
  • Drug/CDx alignment strategy with pharma partner
  • Target product profile creation
  • Joint agency planning (FDA/EMA)
  • Payer-aligned study planning and value proposition development 
  • Raw CLSI-compliant analytical validation studies
  • Verification protocols aligned with ISO 20916
  • Study design aligned with therapeutic trials
  • Support for investigational use clearance (e.g., IVDR Article 5 or 58, Annex XIII/Annex XIV)
  • Patient selection criteria and statistical planning
  • Clinical evidence strategy aligned with reimbursement expectations
  • Regulatory and technical documentation preparation (Annex I/II/III)
  • Device-side QMS alignment (ISO 13485)
  • FDA PMA, IDE, or pre-submission meeting support
  • EC/CA performance study submission support
  • IVDR Technical Documentation (Annex II/III, PER, SVR)
  • IVDR compliance for in house tests (article 5(5))
  • UKCA readiness
  • Documentation for performance study/investigational use (EU and U.S.)
  • Final regulatory hand-off for commercial or investigational use
  • Launch support aligned with therapy indication approvals
  • PLA/CPT code confirmation and coverage planning
  • CDx-specific PMPF plans and studies
  • Revalidation strategies for evolving biomarker use cases
  • Real-world evidence generation for HTA and payer updates
  • Labeling updates and therapy indication alignment
  • PER and SVR updates for new drug indications or populations
  • Regulatory impact assessments
  • Global access and market expansion support
Full-Service Outsourcing

Full-Service Outsourcing

Fully managed CDx regulatory and clinical programs integrated with therapeutic timelines or stand-alone diagnostics programs.

End-to-end project ownership, from strategy to execution. Our managed outsourcing solutions enable easy collaboration, streamlined operations, and expert oversight so you can focus on what you do best.

Professional Consulting

Professional Consulting

Strategic guidance on co-development models, clinical trial use-only documentation, regulatory submissions, and performance data.

Industry-leading MedTech consultants with the strategic insight and regulatory expertise to solve your toughest challenges. Our global team stays ahead of evolving regulations to keep your innovations moving forward.

Professional Staffing

Professional Staffing

Embedded CDx experts to support development, agency interactions, and global compliance efforts.

Need an expert or a full team? We provide highly qualified MedTech professionals who integrate quickly and easily into your organization — the right people, right when you need them.

Partner with the Experts in Companion Diagnostics

Whether you’re pursuing FDA PMA approval, IVDR compliance for in-house tests or for investigational use in performance studies, or payer-ready HTA strategy, RQM+ brings unmatched regulatory and clinical strength to your CDx journey.

Contact us to accelerate your companion diagnostic to market or clinic.

Talk to an Expert